GeneDx (NASDAQ: WGS) revenue
GeneDx reported revenue of $427.5m for fiscal 2025, 40.0% more than in fiscal 2024 ($305.5m). Since fiscal 2020 its revenue has grown by 138.4%, an average growth of 19.0% a year.
GeneDx has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 6 fiscal years on record. The biggest drop was in fiscal 2023, −13.7%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $427.5m | +40.0% | −$13.1m | −3.1% |
| 2024 | $305.5m | +50.8% | −$23.2m | −7.6% |
| 2023 | $202.6m | −13.7% | −$180.6m | −89.2% |
| 2022 | $234.7m | +10.6% | −$667.7m | −284.5% |
| 2021 | $212.2m | +18.3% | −$446.1m | −210.3% |
| 2020 | $179.3m | — | −$242.0m | −134.9% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
GeneDx revenue compared with its sector
By revenue for its latest fiscal year, GeneDx ranks 200th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; GeneDx, 40.0%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 198th | Tarsus Pharmaceuticals | $451.4m | 146.7% |
| 199th | Artivion | $441.3m | 13.6% |
| 200th | GeneDx | $427.5m | 40.0% |
| 201st | Certara | $418.8m | 8.7% |
| 202nd | MiMedx Group | $418.6m | 20.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of GeneDx
- How much revenue did GeneDx make in fiscal 2025?
- GeneDx reported revenue of $427.5m for fiscal 2025, compared with $305.5m in fiscal 2024.
- How much has the revenue of GeneDx grown?
- Between fiscal 2020 and fiscal 2025 it went from $179.3m to $427.5m: 138.4% more, an average growth of 19.0% a year.
- What was the best year for revenue at GeneDx?
- Of its last 6 fiscal years, fiscal 2025, with $427.5m.
- Where does GeneDx rank in its sector by revenue?
- It ranks 200th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for GeneDx come from?
- From the annual report (Form 10-K) that GeneDx files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that GeneDx files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on GeneDx: the GeneDx page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.